Dr. Shoemaker and CIRS: Why His Name Dominates the Mold Illness Conversation
If you have been reading about mold-related illness, Dr. Shoemaker shows up quickly. Dr. Ritchie Shoemaker is a physician who helped popularize the term Chronic Inflammatory Response Syndrome (CIRS), along with a structured way to evaluate people who feel unwell after time in water-damaged buildings.
Think of CIRS as a smoke alarm that will not stop beeping. The original trigger might be smoke, but now the alarm is stuck in “on” mode. Dr. Shoemaker’s work focuses on the idea that, in some people, certain exposures can set off a persistent inflammatory pattern that affects multiple body systems at once—energy, sleep, mood, memory, pain, digestion, and breathing.
According to a 2024 review in Annals of Medicine & Surgery, CIRS is described as an acquired condition involving innate immune dysregulation after exposure to water-damaged buildings, with symptoms that can involve multiple organ systems.
Who Is Dr. Ritchie Shoemaker?
Dr. Shoemaker trained in family medicine and spent decades in clinical practice before focusing increasingly on biotoxin-associated illness and the health complaints reported after certain environmental exposures. Much of the public information about his background, writings, and clinical approach lives on the Surviving Mold site and related educational channels.
His framework for understanding and treating these conditions has become the most widely referenced approach in the mold illness community, shaping how both patients and practitioners discuss this category of illness.
What Most Researchers Agree On About Damp Buildings and Health
It helps to separate two conversations that often get mashed together:
Conversation A: Dampness and mold in buildings are linked with certain health problems, especially respiratory and allergic issues.
Conversation B: Whether a specific, named syndrome with a specific testing and treatment pathway explains a broader set of symptoms in a subset of people.
Conversation A has substantial support. When buildings stay damp, microbial growth can increase and irritants can accumulate. That combination has been repeatedly associated with more respiratory symptoms and asthma-related outcomes.
According to meta-analyses published in Indoor Air, dampness and mold in homes were associated with increased odds of several respiratory and asthma-related outcomes, with estimates suggesting meaningful population-level impact.
A 2011 review in Environmental Health Perspectives confirmed that the epidemiologic literature supports associations between indoor dampness or mold and respiratory symptoms, asthma development or exacerbation, and some allergic outcomes.
And if you want the “what do we do about it” message in one sentence, it is simple: keep your home dry. The most effective way to reduce adverse health effects is preventing or minimizing persistent dampness and microbial growth in your home. This means monitoring humidity levels and using dehumidifiers. Pro tip– have your shower and bathtub area inspected. Many times, there can be hidden water leaks, creating mold behind shower walls and nearby sheetrock.
Where the Controversy Starts
Now we move into Conversation B, where there is more disagreement.
Some clinicians, including Dr. Shoemaker, argue that a subset of people develop a predictable inflammatory pattern after certain exposures, and that the pattern can be tracked with specific lab markers and clinical steps. Others argue that while mold can clearly worsen allergies and asthma, the evidence for broader, exposure-driven syndromes is less settled, and that symptoms may have multiple overlapping causes.
According to a position statement in the Journal of Allergy and Clinical Immunology, mold exposure can cause disease through well-established mechanisms like allergy and hypersensitivity, while many additional proposed mold-related illnesses have been hypothesized with limited proof—which is a major reason debates persist.
That difference in framing matters. If you believe the main problem is allergy or asthma, you focus on traditional evaluation and remediation. If you believe the main problem is a stuck inflammatory signaling pattern, you might pursue a broader “systems” workup.
How Dr. Shoemaker Describes CIRS in Practical Terms
Dr. Shoemaker’s model is often explained as a sequence:
- Trigger: Exposure to something biologically active in a damp building environment
- Susceptibility: Not everyone reacts the same way, and genetics may influence risk
- Immune signaling shift: Inflammatory messengers rise and fall out of balance
- Symptoms: A multi-system cluster rather than one single complaint
A useful analogy is a thermostat. In a normal system, the thermostat senses a change, turns the heat on, then turns it off once the target is reached. In a “stuck” system, the thermostat keeps calling for heat even when the room is already hot. Dr. Shoemaker’s clinical approach tries to identify whether a person looks like that “stuck thermostat” pattern, then tries to guide it back to baseline.
What Testing Tries to Capture, and What It Cannot Prove by Itself
A common frustration is wanting a single test that says “yes, you have mold illness” or “no, you do not.” Real life is messier.
In Dr. Shoemaker’s framework, blood markers are used more like dashboard gauges than a single yes-or-no light. One gauge might reflect inflammation signaling, another might hint at hormone regulation or vascular effects. A pattern across multiple markers can be more informative than any single value.
If you want to take the next step and see where your markers fall, you can order a CIRS biomarker panel that covers the tests commonly used in this framework.
At the same time, it is worth keeping expectations grounded: abnormal labs do not automatically prove cause, and normal labs do not automatically exclude a problem. Labs are clues, not verdicts. The most useful testing is paired with a careful history, timing (when symptoms worsen or improve), and a realistic look at other explanations that can mimic the same symptom cluster.
Where Genetics May Fit In
One reason Dr. Shoemaker’s name is tied so closely to CIRS is his emphasis on the idea that susceptibility varies. Two people can spend time in the same building, and one might feel fine while the other deteriorates.
A practical way to think about this is sun exposure. Two people can stand in the same sun for the same hour, but one burns badly while the other barely changes. It does not mean the sun is imaginary, and it does not mean the person who burned is “making it up.” It means vulnerability differs.
The genetic component most often discussed involves HLA gene patterns, which influence how the immune system recognizes and processes foreign substances. For those who want to explore whether they carry susceptibility markers, the HLA DR + DQ genetic test is the test commonly referenced in mold-exposure discussions.
Why Urine Testing Enters the Conversation
Another common question is whether someone should look for evidence of biotoxin exposure directly. Some clinicians use urine mycotoxin testing as one piece of the puzzle, particularly when the goal is to document exposure signals that might support a broader investigation.
A careful way to interpret urine results is to treat them like a fingerprint at a scene. A fingerprint suggests contact, but it does not automatically prove the whole story of what happened, when it happened, or whether it is responsible for every symptom in the room. It can be meaningful, but it is rarely the only answer.
If you are trying to document mycotoxin exposure, the MycoTox urine mycotoxin test is one of the most commonly used panels in this space.
How Dr. Shoemaker’s Research Is Commonly Cited
Supporters of the Shoemaker approach often point to published work exploring symptom patterns, biomarkers, and clinical outcomes in people reporting illness after exposure to water-damaged buildings.
For example, Dr. Shoemaker co-authored a clinical trial and mechanistic discussion published in Neurotoxicology and Teratology, examining how occupants of water-damaged buildings can report multi-system symptoms and may be exposed to complex mixtures of fungi, bacterial components, and biologically produced compounds.
He has also published a volumetric MRI study describing imaging findings in a small cohort of patients evaluated for inflammatory illness after water-damaged building exposure, with discussion of inflammatory markers and blood-brain barrier permeability as a proposed mechanism.
These papers do not end debate, but they help explain why Dr. Shoemaker is frequently referenced—he has tried to publish a coherent clinical model rather than only anecdotal claims.
A Public Example That Drew Attention
From time to time, public conversations about complex chronic illness bring CIRS into the spotlight. One example that circulated widely online was commentary from Jordan Peterson’s family about his health struggles and the possibility that CIRS might be involved.
You can read that discussion here: Mikhaila Peterson on Jordan Peterson’s health and CIRS.
The value of these stories is not that they diagnose anyone. The value is that they show how people—especially those who feel dismissed—look for frameworks that explain a messy set of symptoms. Dr. Shoemaker’s framework is one of the most commonly cited in that space.
How to Think About Next Steps If You Suspect a Building Is Involved
If you are trying to make sense of symptoms that seem tied to a building, a grounded approach can reduce overwhelm:
Start with timing. Do symptoms improve away from the building and worsen when you return?
Address obvious moisture issues. Fix leaks, control humidity, remove water-damaged materials, improve ventilation. These interventions benefit health regardless of whether CIRS specifically is involved.
Cover the basics first. Make sure asthma, allergies, sleep apnea, thyroid issues, anemia, medication effects, and mood disorders are not being missed.
Use testing to answer specific questions. “Do I show an inflammatory pattern that matches this situation?” is more useful than using labs to “prove everything.”
Re-check after changes. Do your CIRS lab test markers improve after making changes like removing yourself from the mold source?
This is also where it helps to be honest about uncertainty. Some people improve dramatically with environmental changes and targeted medical support. Others find that mold was one factor among several, and they need a broader plan.
Frequently Asked Questions About Dr. Shoemaker and CIRS
Is Dr. Shoemaker the inventor of CIRS?
He is one of the most visible clinicians associated with the term and the most commonly referenced structured approach. The concept overlaps with older ideas like building-related illness and sick building syndrome, but “CIRS” and the clinical pathway many people describe online is strongly associated with Dr. Shoemaker.
Does mainstream medicine accept CIRS?
There is agreement that damp buildings can worsen respiratory and allergic disease, but there is more debate about CIRS as a distinct, broadly explanatory syndrome with a specific testing and treatment protocol. If you hear strongly polarized opinions, that is usually why.
Why do people say CIRS is “multi-system”?
Because the symptom clusters people report often span more than one body system—fatigue plus sleep disruption plus brain fog plus pain plus gut issues. In Dr. Shoemaker’s framework, that multi-system pattern is part of the signal that this is not just a single-organ problem.
What is the most practical takeaway?
Do not ignore water damage. Fixing moisture problems is worthwhile for health and for the building itself. Then, if symptoms persist, consider a stepwise medical evaluation that covers both common causes and exposure-related possibilities.
